See more : Filtronic plc (FTC.L) Income Statement Analysis – Financial Results
Complete financial analysis of Columbia Care Inc. (CCHWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Columbia Care Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Jacobs Engineering Group Inc. (J) Income Statement Analysis – Financial Results
- Koito Manufacturing Co., Ltd. (KOTMY) Income Statement Analysis – Financial Results
- Sykes Enterprises, Incorporated (SYKE) Income Statement Analysis – Financial Results
- Sonova Holding AG (SONVY) Income Statement Analysis – Financial Results
- TRxADE HEALTH, Inc. (MEDS) Income Statement Analysis – Financial Results
Columbia Care Inc. (CCHWF)
About Columbia Care Inc.
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 511.58M | 460.08M | 179.50M | 77.46M | 0.00 |
Cost of Revenue | 310.37M | 266.07M | 113.53M | 40.60M | 0.00 |
Gross Profit | 201.21M | 194.02M | 65.98M | 36.86M | 0.00 |
Gross Profit Ratio | 39.33% | 42.17% | 36.76% | 47.59% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 203.69M | 179.48M | 118.34M | 105.44M | 0.00 |
Selling & Marketing | 14.17M | 16.26M | 6.08M | 5.79M | 0.00 |
SG&A | 617.45M | 195.73M | 124.42M | 111.24M | 0.00 |
Other Expenses | -16.45M | 36.32M | 15.65M | 7.45M | 0.00 |
Operating Expenses | 617.45M | 232.05M | 140.07M | 118.68M | 0.00 |
Cost & Expenses | 927.82M | 498.12M | 253.60M | 159.28M | 0.00 |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 53.90M | 30.01M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 84.79M | 53.00M | 42.02M | 26.26M | 161.14K |
EBITDA | -416.24M | 13.64M | -32.08M | -55.56M | 0.00 |
EBITDA Ratio | -81.36% | 2.96% | -17.87% | -71.73% | 0.00% |
Operating Income | -416.24M | -39.37M | -74.10M | -81.82M | 0.00 |
Operating Income Ratio | -81.36% | -8.56% | -41.28% | -105.63% | 0.00% |
Total Other Income/Expenses | -16.45M | -107.35M | -62.77M | -12.04M | 0.00 |
Income Before Tax | -432.69M | -146.71M | -136.87M | -93.85M | 0.00 |
Income Before Tax Ratio | -84.58% | -31.89% | -76.25% | -121.17% | 0.00% |
Income Tax Expense | -11.21M | 139.00K | -3.67M | 12.87M | 0.00 |
Net Income | -421.48M | -146.85M | -133.20M | -106.73M | 0.00 |
Net Income Ratio | -82.39% | -31.92% | -74.20% | -137.79% | 0.00% |
EPS | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
EPS Diluted | -1.16 | -0.43 | -0.57 | -0.51 | 0.00 |
Weighted Avg Shares Out | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
Weighted Avg Shares Out (Dil) | 363.17M | 338.75M | 232.58M | 209.99M | 209.99M |
Cannabis company Columbia Care to cut costs and sell its Florida business
Top Marijuana Stocks To Kick Off October
Top Cannabis Stocks with the Most Impressive Gains
The Cannabist Company Announces Closing of US$25 Million Private Placement
Columbia Care Unveils New Name and Brand Identity – The Cannabist Company – to Bring Passion and People to the Forefront
Columbia Care announces $25M private placement
Columbia Care Announces Private Placement of US$25 Million and Executes on Next Phase of Balance Sheet Improvement Initiatives
3 Top US marijuana Stocks With Triple Digit Gains In September
Why Are Cannabis Stocks Up Today?
Cannabis MSO shares rise with marijuana banking reform poised to win Senate Committee's approval
Source: https://incomestatements.info
Category: Stock Reports